Full-Time

Vice President

Solutions Engineering

Confirmed live in the last 24 hours

Enfusion

Enfusion

1,001-5,000 employees

Cloud-based platform for investment management

Compensation Overview

$165k - $200k/yr

+ Commission + Benefits

Senior, Expert

New York, NY, USA

Category
Solution Engineering
Sales & Solution Engineering
Requirements
  • 7+ years experience in a sales engineering or implementation role focused on front-office technology (OMS, PMS) serving traditional asset managers and asset owners.
  • Experience in complex, Enterprise sales in FinTech space (Enterprise solutions and services to the front, middle and back offices of Traditional Asset Managers & Asset Owners)
  • Strong understanding of traditional asset manager and asset owner operating models, the investment management lifecycle and vendor landscape.
  • Excellent communication, presentation and collaboration skills.
  • Experience with RFI/RFP processes.
  • Willingness to travel onsite to meet with prospects and clients.
Responsibilities
  • Act as the primary technical point of contact for key stakeholders within institutional asset managers and asset owner prospective clients.
  • Lead technical discovery sessions with prospective clients. Understand & document existing operating models, key business requirements and pain points.
  • Evaluate customer business and technical needs with a consultative approach, collaborate with sales on the sales strategy, and prepare and deliver high quality, ‘solution-led’ demonstrations and conversations to business and technical stakeholders from prospective firms.
  • Field product requirements from prospective customers and interact with the product team when gaps exist.
  • Collaborate with the deal team to develop a competitive strategy to win the deal.
  • Understand the competitive landscape and key differentiators of the Enfusion platform across the multiple lines of businesses Enfusion caters to.
  • Continuously evolve domain expertise with respect to all current developments and enhancements to the Enfusion platform (SaaS and Managed Services).
  • Prepare high-quality responses to RFI/Ps.
  • Display strong technical acumen with an ability to confer with customers and assess their requirements.
  • Effectively handle potential client objections and be able to adapt the demonstration of functional product capabilities to meet clients’ needs.
  • Build trusted relationships with key internal & external stakeholders from procurement through delivery by demonstrating the benefits and value proposition of the Enfusion platform.
  • Use quantifiable metrics to help potential or existing clients with a reduction in cost / time, and-or an improvement in scales and effectiveness by identifying and resolving for business operation pain-points.

Enfusion provides a technology platform designed to assist investment managers in overcoming operational challenges. Their platform integrates various functions such as portfolio management, accounting, order management, execution management, and analytics into a single system that operates in the cloud. This cloud-native approach allows for real-time visibility across different departments, enabling portfolio managers to access the same information as trading desks. Enfusion's platform supports seamless upgrades and the addition of new asset classes, ensuring continuous improvement. The company also offers managed services to help asset managers optimize their operations and control costs. Unlike many competitors, Enfusion focuses on a unified solution that enhances collaboration and efficiency across all levels of asset management. The primary goal of Enfusion is to empower investment managers to concentrate on generating returns for their investors by removing operational barriers.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

1997

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased demand for integrated compliance solutions boosts Enfusion's market position.
  • SaaS platform consolidation enhances operational efficiency for clients.
  • Focus on margin optimization is crucial for hedge funds in current economic climate.

What critics are saying

  • Emerging fintech companies may erode Enfusion's market share.
  • Rapid technological advancements could strain Enfusion's resources.
  • Dependency on third-party services like SteelEye poses operational risks.

What makes Enfusion unique

  • Enfusion offers a cloud-based portfolio management and risk system.
  • The company provides exceptional client service and outsourced fund services.
  • Enfusion partners with firms like SteelEye for seamless compliance solutions.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Unlimited Paid Time Off

Commuter Benefits

Employee Assistance Program

Company News

PYMNTS
Jan 17th, 2025
Fintech Ipo Index Gains 3% As Katapult Shares Vault Higher On Q4 Originations

Earnings season is officially here as the big banks weighed in this week. Although the quarterly reports have yet to come through for the denizens of the FinTech IPO Index, there was a notable bit of earnings-related news that sent the stock of Katapult soaring, up more than 49%. Katapult’s 4Q Update

Webrazzi
Jan 14th, 2025
Clearwater, Enfusion’U 1,5 Milyar Dolara Satın Alıyor

Clearwater Analytics, finansal teknoloji sektöründeki etkisini genişletmek amacıyla ABD merkezli yazılım şirketi Enfusion’u 1,5 milyar dolarlık bir anlaşmayla satın alacağını duyurdu.Edwin van Os tarafından kurulan Enfusion'un hissedarlarının her hisse için 5,85 dolar nakit ve Clearwater hissesi alacağını belirtelim. Enfusion'un hisse başına değerini 11,25 dolar olarak belirlendi. Satın alma haberinin ardından şirketin hisseleri yüzde 9 yükseldi.Yatırım portföyleri için finansal raporlama, muhasebe ve analiz hizmetleri sunan bir yazılım şirketi Clearwater CEO'su Sandeep Sahai, satın almanın iki şirketin birbirini tamamlayan hizmetleri sayesinde müşterilere daha kapsamlı bir çözüm sunacağını belirtti. “Clearwater işlem sonrası hizmetlere odaklanırken, Enfusion’un uzmanlık alanı işlem öncesi sistemler. Bu birleşme, müşterilerimiz için büyük bir fırsat yaratacak” diyerek satın alma anlaşmasının öneminin altını çizdi.Hedge fonlar ve yatırım fonlarına portföy yönetim ve risk sistemleri sağlayan Enfusion, 2024 yılı için 201-202 milyon dolar gelir hedefliyor.J.P. Morgan ve Goldman Sachs gibi finans sektörünün bilinen şirketlerinin danışmanlık yaptığı satın almanın, 2025 yılının ikinci çeyreğinde tamamlanması bekleniyor.Bu satın almanın Clearwater’ın uluslararası büyüme stratejisini desteklerken hedge fon sektörüne girmesini sağlıyor diyebiliriz

Business Wire
Mar 21st, 2024
Kayne Anderson Strengthens Investment Operations After Successful Platform Migration To Enfusion

NEW YORK--(BUSINESS WIRE)--Enfusion, a best-in-class software-as-a-service (SaaS) platform for investment managers, today announced the completion of the second phase of a strategic investment management platform migration by Kayne Anderson. Kayne Anderson is a leading alternative investment management firm focused on real estate, infrastructure, energy, credit, and growth capital. The first phase focused on Order and Execution Management and successfully concluded following a three-month disruption-free deployment. The second phase further consolidated Kayne Anderson’s front and back office onto a single platform with the implementation of Enfusion’s accounting module in under seven months. By consolidating previously disparate on-premise systems onto a single SaaS platform, Kayne Anderson has realized workflow optimizations across front-, middle-, and back-office functions. Improved order workflows have led to enhanced productivity and operational efficiency

FF News
Apr 26th, 2023
Steeleye And Enfusion Partner For Seamless Order Management And Trade Supervision

SteelEye and Enfusion have established a partnership to offer joint clients a seamless experience, with trade and order data from Enfusion’s investment management solutions flowing automatically into SteelEye’s integrated compliance platform.Traditionally, the implementation of trade-based compliance systems for surveillance, reporting, and best execution is lengthy and complex. The partnership between SteelEye and Enfusion takes the legwork out of implementing these systems and makes the process seamless. As a result, the onboarding of SteelEye is speedy with minimal effort from investment managers.This was a key driver for Alken Asset Management selecting SteelEye and Enfusion.“As we were diversifying our internal trading and compliance systems, we were looking for tools that would make the migration smooth and easy – and this is what we received with SteelEye and Enfusion. In fact, Alken Asset Management’s data was flowing from Enfusion into SteelEye’s UAT environment before we had even initiated the onboarding kick-off call,” said Divesh Patel – Operations Manager at Alken Asset Management.“We decided to join forces with Enfusion to deliver additional value to our joint clients. The technical partnership goes a long way to address the pains of onboarding trading and compliance systems. In addition, joint clients get seamless access to SteelEye’s Integrated Surveillance tools which include archiving and communications monitoring – enabling them to do more with less,” added Matt Smith, CEO of SteelEye.Also commenting on the announcement, Peter Salvage, Managing Director, Global Head of Channel & Alliance Partnerships at Enfusion, said: “We are delighted that Alken Asset Management selected Enfusion and SteelEye

FF News
Dec 20th, 2022
Exclusive: "A New Normal?" - Christian Kahl Phd, Fincad And Gennadiy Friedman, Enfusion In 'The Fintech Magazine'

Technology and regulation have moved on since the last global recession, giving investors better tools to navigate what looks likely to be a year of extreme uncertainty – one in which none of the old rules about economic performance seem to apply. We asked two leading providers to the market – Christian Kahl PhD, President of FINCAD, the capital markets division of Zafin, and Gennadiy Friedman, MD of Enfusion – for their analysisTHE FINTECH MAGAZINE: How do market conditions today compare with the financial crisis of 2008 and how have changes since then shaped the current environment for hedge funds?GENNADIY FRIEDMAN: After 2008, hedge funds went through significant regulatory and risk management changes. Now, most hedge funds are required to be registered. There’s also a big emphasis on due diligence and transparency. The introduction of UMR, which stands for uncleared margin rules, has increased the focus on collateral management practices. Initial margin is almost entirely value-at-risk (VaR) stress-test-based these days, and, overall, margin optimisation is playing quite a significant role in the trading decision-making process